The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

October 1999

Volume 39, Issue 10

Pages 995–1093

  1. Therapeutic Review

    1. Top of page
    2. Therapeutic Review
    3. Drug Development
    4. Pharmacokinetics and Pharmacodynamics
    5. Clinical Trials
    6. Pediatrics
    7. Drug Interactions
    1. P-glycoprotein and Drug Therapy in Organ Transplantation (pages 995–1005)

      Agnes Lo and Gilbert J. Burckart

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011755

  2. Drug Development

    1. Top of page
    2. Therapeutic Review
    3. Drug Development
    4. Pharmacokinetics and Pharmacodynamics
    5. Clinical Trials
    6. Pediatrics
    7. Drug Interactions
  3. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Therapeutic Review
    3. Drug Development
    4. Pharmacokinetics and Pharmacodynamics
    5. Clinical Trials
    6. Pediatrics
    7. Drug Interactions
    1. Disposition of Recombinant Human Interleukin-10 in Subjects with Various Degrees of Renal Function (pages 1015–1020)

      Mr. Scott R. Andersen, Dr. Lawrence J. Lambrecht, Dr. Suzanne K. Swan, Dr. David L. Cutler, Dr. Elaine Radwanski, Dr. Melton B. Affrime and Dr. Jean-Jacques Garaud

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011773

    2. The Pharmacokinetics of Extended-Release Formulations of Calcium Antagonists and of Amlodipine in Subjects with Different Gastrointestinal Transit Times (pages 1021–1031)

      Torsten Zimmermann, Heinrich Laufen, Rodney Yeates, Friedrich Scharpf, Klaus-Dieter Riedel and Tilo Schumacher

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011782

    3. Bioequivalence of 1 and 5 mg Tacrolimus Capsules Using a Replicate Study Design (pages 1032–1037)

      Dr. Ihor Bekersky, Ms. Dawna Dressler, Dr. Wayne Colburn and Dr. Qais Mekki

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011791

    4. The Effect of Pharmacokinetically Guided Acute Intravenous Testosterone Administration on Electrocardiographic and Blood Pressure Variables (pages 1038–1043)

      Dr. C. Michael White, Dr. Melissa J. Ferraro-Borgida, Dr. Niall M. Moyna, Ms. Carol C. McGill, Mr. Alan W. Ahlberg, Dr. Paul D. Thompson and Dr. Gary V. Heller

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011809

    5. Pharmacokinetics, Safety, and Tolerability of Single Intravenous Infusions of an Adenosine Agonist, AMP 579, in Healthy Male Volunteers (pages 1044–1052)

      Dr. Peter N. Zannikos, Dr. Robert I. Baybutt, Dr. Bruno X. Boutouyrie, Dr. Bharti Shah, Dr. Thomas L. Hunt and Dr. Bradford K. Jensen

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011818

    6. Fluoxetine Bioequivalence Study: Quantification of Fluoxetine and Norfluoxetine by Liquid Chromatography Coupled to Mass Spectrometry (pages 1053–1061)

      M. O. Moraes, F. E. Lerner, G. Corso, F. A. Frota Bezerra, M.E.A. Moraes and G. De Nucci

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011827

  4. Clinical Trials

    1. Top of page
    2. Therapeutic Review
    3. Drug Development
    4. Pharmacokinetics and Pharmacodynamics
    5. Clinical Trials
    6. Pediatrics
    7. Drug Interactions
    1. The New Topical Steroid Ciclesonide Is Effective in the Treatment of Allergic Rhinitis (pages 1062–1069)

      Dr. Bernhard M. W. Schmidt, Dr. Wolfgang Timmer, Ms. Anette C. Georgens, Ms. Monika Hilt, Dr. Catherine Mattinger, Dr. Wilhelm Wurst, Prof. Karl Hörmann and Prof. Martin Wehling

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011836

  5. Pediatrics

    1. Top of page
    2. Therapeutic Review
    3. Drug Development
    4. Pharmacokinetics and Pharmacodynamics
    5. Clinical Trials
    6. Pediatrics
    7. Drug Interactions
    1. No Effect of Gender or Age on Binding Characteristics of Valproic Acid to Serum Proteins in Pediatric Patients with Epilepsy (pages 1070–1076)

      Yasuo Kodama, Dr. Hirofumi Kodama, Masae Kuranari, Dr. Kimiko Tsutsumi, Shunsuke Ono and Dr. Akio Fujimura

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011728

  6. Drug Interactions

    1. Top of page
    2. Therapeutic Review
    3. Drug Development
    4. Pharmacokinetics and Pharmacodynamics
    5. Clinical Trials
    6. Pediatrics
    7. Drug Interactions
    1. Trimethoprim/Sulfamethoxazole Does Not Affect the Steady-State Disposition of Indinavir (pages 1077–1084)

      Dr. Marc G. Sturgill, Dr. James R. Seibold, Dr. Susan E. Boruchoff, Dr. Kuang C. Yeh, Ms. Heidi Haddix and Dr. Paul Deutsch

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011737

    2. Altered Pharmacokinetics of Indinavir by a Novel Nonnucleoside Reverse Transcriptase Inhibitor (HBY-097): A Pharmacokinetic Evaluation in HIV-Positive Patients (pages 1085–1093)

      Dr. Sandra Hayashi, Dr. Deepthi Jayesekera, Dr. Anura Jayewardene, Dr. Anita Shah, Dr. Lourdes Thevanayagam and Dr. Francesca Aweeka

      Version of Record online: 8 MAR 2013 | DOI: 10.1177/00912709922011746

SEARCH

SEARCH BY CITATION